Clinical Trials · NCT04290429

Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

Name: Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedEARLY_Phase 1Teduglutide

Phase: EARLY_Phase 1
Recruitment status: Completed
Sponsor: University of Freiburg
Enrollment: 6
Start date: Dec 2017
Locations: 1 site, Germany
Primary endpoint: Paneth cell numbers

View Teduglutide compound reference